← brief for 2026-08-13 · Slowing decline
Evaluation Of Renal and Cardiovascular Outcomes with Dapagliflozin Plus Telmisartan in Patients with Diabetic Nephropathy
Key takeaways
A trial of two drugs used together to slow kidney decline in diabetes patients. This study used 100 patients for 2 years.
Who did this work
Ambala Syama*, Asma Bano, Banda Vaishnavi, Nallavelli Lalith Adithya, Shanigaram Deekshith Reddy
Source
Paper · OpenAlex, CKD works · 2026-08-12
https://doi.org/10.5281/zenodo.21901590